ICON plc (ICLR) Ordinary EUR0.06

Sell:$142.94Buy:$143.27Price decreased$0.27 (0.19%)

NASDAQ:Price increased0.05%
Market closed |
Prices delayed by at least 15 minutes
Sell:$142.94
Buy:$143.27
Change:Price decreased$0.27 (0.19%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$142.94
Buy:$143.27
Change:Price decreased$0.27 (0.19%)
Market closed |
Prices delayed by at least 15 minutes

Company Information

About this company

ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

Key people

Ciaran Murray
Independent Chairman of the Board
Barry Edward Balfe
Chief Executive Officer, Director
Nigel Clerkin
Chief Financial Officer
Ronan Murphy
Lead Independent Director
Kevin Egan
Director
Jeffrey Thomas Elliott
Director
John Climax
Independent Director
Click to see more

Key facts

  • Shares in issue
    76.57m
  • EPIC
    ICLR
  • ISIN
    IE0005711209
  • Location
    Ireland
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    $11.31bn
  • Employees
    40,100
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.